Showing results (321-330 of 969) with videos related to
Sort By:
Pageof 97
Children (Basel, Switzerland)|September 14, 2019
Biologic Treatment Options for Pediatric Psoriasis and Atopic DermatitisAbigail Cline, Gregory J Bartos, Lindsay C Strowd, et al.Skinmed|October 28, 2016
First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare CostsSteven R Feldman, Eugenia Levi, Prathamesh Pathak, et al.Journal of the American Academy of Dermatology|April 4, 2008
To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasisWilliam Huang, Kelly M Cordoro, Sarah L Taylor, et al.Journal of the American Academy of Dermatology|June 3, 2008
Written action plans: potential for improving outcomes in children with atopic dermatitisSarah S Chisolm, Sarah L Taylor, Rajesh Balkrishnan, et al.Dermatologic Clinics|May 25, 2024
Adherence to Psoriasis TherapiesKawaiola C Aoki, Summer Wong, Jessica Q Duong, et al.Archives of Dermatological Research|July 11, 2023
Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agentsSarah N Rimmer, Rithi J Chandy, Danyaal Khan, et al.Expert Review of Clinical Immunology|July 31, 2026
Ustekinumab for the treatment of psoriasis: a well-established therapy primed for resurgenceOmar Raheel, Alexander Uche, Pauline Do, et al.Skin Appendage Disorders|May 13, 2016
Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid DatabasesScott A Davis, Hsien-Chang Lin, Rajesh Balkrishnan, et al.Dermatitis : Contact, Atopic, Occupational, Drug|March 27, 2020
Frequency of Allergenic Ingredients in Antifungal CreamsNicole Ufkes, Wasim Haidari, Jennifer Su, et al.Dermatology Online Journal|February 7, 2022
The Impact of teledermatology during the COVID-19 pandemicPooja Shah, Deborah N Dorrell, Steven R Feldman, et al.Pageof 97